Please assess the completion status of the following clinical trial:

Trial Title: TENS Trial to Prevent Neuropathic Pain in SCI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18;~* Traumatic spinal cord injury;~* Date of injury occurring within four months of study enrollment.~Exclusion Criteria:~* More than four months since date of injury;~* Contraindications for the study intervention, transcutaneous electrical nerve stimulation (TENS),88 including:~* Implanted electronic device such as a pacemaker;~* Cardiovascular problems;~* Pregnancy;~* Epilepsy;~* Cancer;~* Persons with a spinal cord injury at the C2 level, as placement of TENS electrodes on the neck is not recommended;~* Cognitive dysfunction which limits the ability of the participant to adequately understand procedures and risks.~* Prisoners~* Pregnant Women~Special populations:~* Adults unable to consent: excluded from study~* Individuals -who are not yet adults: individuals who are less than 18 years old will be excluded from the study~* Pregnant women: Women who are known to be pregnant will not be recruited into the study. A pregnancy test will be administered to females prior to enrollment in TENS (or sham) treatment. Women who become pregnant before or during the 8-week TENS treatment period will be discontinued from the study. Women who become pregnant after the 8-week TENS treatment portion of the study will continue to be enrolled, and followed according to protocol guidelines (no information will be collected specifically on the pregnancy or fetus).~* Prisoners: excluded from study~* Neonates: not applicable

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active TENS (Type: EXPERIMENTAL): Participants are given 30 minutes of TENS therapy twice a week for 8 weeks.
- Sham TENS (Type: SHAM_COMPARATOR): Electrodes are placed on participants for 30 minutes twice a week for 8 weeks without TENS stimulation.

Based on this trial design, predict the completion outcome and termination type (if applicable).